BOLD vs META · P/E 0.1, $24.6M cap vs P/E 29, rev $200.97B
Boundless Bio, Inc. Common Stock (BOLD) versus Meta Platforms Inc. (META) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Meta Platforms Inc. (META) is a internet content & information company listed on US. It is led by Mark Zuckerberg.
BOLD does not have a complete income-statement cache yet.
Latest reported META revenue for 2025-12-31 was $200.97B. Net income was $60.46B. Revenue was up 22.2% from 2024-12-31 to 2025-12-31. META currently screens at market cap $1.64T and trailing P/E 28.8.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. META currently screens at market cap $1.64T and trailing P/E 28.8.
Not investment advice. Open the BOLD and META stock pages for the full models.
Not investment advice.